These 4 Marijuana Stocks Could Be Positioned For A Big Month

CORAL GABLES, FL / ACCESSWIRE / February 8, 2019 / The marijuana stock market, as many have come to recognize, has existed for a short period of time relative to other more established markets. Due to this fact, there have been quite a bit of volatility surrounding companies in the cannabis industry. However, as several analysts have pointed out, this volatility can be considered to be a positive indicator of the sheer amount of investors paying attention to cannabis. In the first few months of the new year, companies have seen bullish returns, signaling the notion that public opinion, coupled with investor attention, has increasingly become more favorable over time. As we continue to move through the month of February, the hope is that the cannabis industry will recognize even more gains in the future. Biome Grow Inc (CSE:BIO) (BIOIF) (6OTA.F), Pyxus International Inc (PYX), Amyris Inc (AMRS), and Trulieve Cannabis Corp (OTC PINK: TCNNF) are four cannabis companies focused on cultivating and manufacturing high-quality products for consumers in the cannabis market.

Biome Grow Inc (CSE:BIO) (BIOIF) (6OTA.F) is a company poised to become the next Canadian cannabis conglomerate. Biome's expert leadership team has made sure to maintain a diversified set of holdings for the Company, across sectors such as finance, growing technologies, regulatory affairs, business building, and marketing. Having learned from mistakes made by other companies in the space, Biome Grow is quickly becoming one of Canada's leaders in medical and recreational cannabis businesses.

Biome Grow Inc (CSE:BIO) (BIOIF) (6OTA.F) today announced that the Company just rebased its first shipments of finished products to Newfoundland and Labrador. Products are expected to be delivered directly to retail locations across the two Canadian regions and will be accessible to customers in the coming weeks. Per the details of the announcement, the first shipments will assist in reducing the immediate supply shortage in the domestic cannabis market, following Canada's nation-wide legalization of adult-use recreational cannabis.

As part of the landmark agreement between Biome Grow Inc (CSE:BIO) (BIOIF) (6OTA.F) and its Newfoundland and Labrador brand, Back Home Medical Cannanbis Corporation, the first shipment represents a key component of the largest cannabis supply agreement in Atlantic Canada, as well as one of the top five largest deals of its kind in the Canadian cannabis market by quantity.

For More Information On Biome Grow Inc, Click Here

Pyxus International Inc (PYX) announced, at the tail-end of January, that one of its partners, Criticality, a North Carolina-based agricultural hemp company, will be expanding its consumer products under its brand name Korent with the launch of its line of cannabidiol (CBD) e-liquids. The announcement follows the brand's launch of CBD oils in December 2018.

Following the announcement, Brian Moyer, Chief Executive Officer of Criticality, said, "Korent's CBD products are expertly crafted and designed to help consumers effectively restore balance to their lives. Our new line of CBD e-liquids uses high-quality, verifiable ingredients. Criticality provides unparalleled transparency into the production of our industrial hemp and hemp-derived products. The company's expertise in extraction and purification technologies enables us to produce superior hemp products that adhere to the highest quality standards."

For More Information On Pyxus International Inc, Click Here

Amyris Inc (AMRS), a leader in the development and production of sustainable ingredients for health and wellness products, announced earlier this week that it has signed a binding terms sheet for a planned cannabinoid development, licensing and commercialization partnership valued at up to $255 million with a confidential partner. The $255 million in payments include an upfront payment and the remainder is linked to milestones that are expected over the next 12-36 months following the signing of a definitive final agreement.

John Melo, Amyris President & CEO, commented, "the dollar value of this agreement and our roster of partners who are leaders in global markets combine to be a strong endorsement of our technology platform and ability to bring No Compromise^â„¢, sustainably-produced products to market."